Study finds targeted treatment method has less than half the risk of dysfunction compared with standard techniques
Study finds targeted treatment method has less than half the risk of dysfunction compared with standard techniques
Copy link
Fewer men are undergoing unnecessary biopsies, which can have harmful side-effects, report finds
A wave of British scientific breakthroughs is poised to transform how prostate cancer is found and treated
Personalised immunotherapy can keep disease at bay for more than four years
NHS-backed programme will give men rapid access to new treatments for the best chance of a ‘longer, healthier life’
Offering blood tests to men aged 45 and 70 could mean around 820 a year have their cancer caught earlier
Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the disease…
